Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc. ...Middle East

AJICAP® Antibody-Drug Conjugate Manufacturing Technology Contributes to Enhanced Efficacy of Antibody Drugs TOKYO, May 6, 2025 /PRNewswire/ -- Ajinomoto Co., Inc. (President: Shigeo Nakamura, Headquarters: Chuo-ku, Tokyo, hereinafter referred to as "Ajinomoto") has been conducting joint...

Read More Details
Finally We wish PressBee provided you with enough information of ( Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc. )

Also on site :

• Walmart Has 'Awesome' $144 Linen Blackout Curtains for Only $38, and Shoppers Say They 'Block Out So Much Light'
• 9 Best Moisturizers for Dry Skin, According to Celebrity Estheticians
• Judge seeks more information from Trump administration about prison deal with El Salvador